CBLB and neoplasm: The expression of Cbl-b in tumor-infiltrating immune cells is significantly higher than that in normal tissues, and the expression of Cbl-b is significantly lower in the immune cells of the patients with autoimmune diseases such as regulatory T cells from systemic lupus erythematosus (7).